Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

Europace. 2010 Oct;12(10):1360-420. doi: 10.1093/europace/euq350.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Acute Coronary Syndrome / epidemiology
  • Acute Coronary Syndrome / therapy
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Anti-Arrhythmia Agents / therapeutic use
  • Anticoagulants / therapeutic use
  • Athletes / statistics & numerical data
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / epidemiology
  • Atrial Fibrillation / etiology
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Cardiomyopathy, Hypertrophic / epidemiology
  • Comorbidity
  • Diabetes Mellitus / epidemiology
  • Electric Countershock / instrumentation
  • Electric Countershock / methods
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Heart Failure / drug therapy
  • Heart Failure / epidemiology
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Heart Valve Diseases / epidemiology
  • Heart Valve Diseases / therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperthyroidism / epidemiology
  • Lung Diseases / epidemiology
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Pregnancy
  • Prevalence
  • Wolff-Parkinson-White Syndrome / epidemiology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Anti-Arrhythmia Agents
  • Anticoagulants
  • Fibrinolytic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Mineralocorticoid Receptor Antagonists
  • Platelet Aggregation Inhibitors